Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The 403 placeholder is replaced by the clinical trial record, including study design, eligibility criteria, outcome measures, locations, and study documents.
    Difference
    55%
    Check dated 2026-11-09T13:38:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-02T13:30:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T14:14:46.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details and downloadable documents with an access-restricted page.
    Difference
    19%
    Check dated 2026-09-21T21:52:45.000Z thumbnail image

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.